Early evidence of efficacy in patients (pts) with non-small cell lung cancer (NSCLC) with HER2 exon20 insertion (ex20ins) mutations treated in a phase I study with BAY 2927088
Refereed conference paper presented and published in conference proceedings
Full Text
Digital Object Identifier (DOI) DOI for CUHK Users View Full-text in Publisher Website |
Altmetrics Information
.
Other information
All Author(s) ListLoong H.H.F., Daniele G., Yang T-Y., Leal T.A., Goto K., Shinno Y., Nishino K., Sakamoto T., Felip E., Ruffinelli J.C., Gallot N., Wang Z., Chen C., Brennan B., Pu S-F., Kornacker M., Grassi P., Le X., Tan D.S.W., Goh B-C.
Name of ConferenceAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO)
Start Date of Conference20/10/2023
End Date of Conference24/10/2023
Place of ConferenceBarcelona
Country/Region of ConferenceSpain
Proceedings TitleAnnals of Oncology
Detailed descriptionAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, OCT 20-24, 2023
Year2023
Month10
Volume Number34
Issue NumberSuppl 2
PublisherELSEVIER
PagesS761 - S762
ISSN0923-7534
LanguagesEnglish-United States
